Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 February 2002

Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary study

Anna Sysa-Jedrzejowska, Anna Zalewska, Elzbieta Waszczykowska, Maria Łuczyńska, Bozena Dziankowska-Bartkowiak

Med Sci Monit 2002; 8(2): CR108-112 :: ID: 420931


BACKGROUND: The etiopathogenesis of systemic sclerosis (SSc)--an autoimmunologicaldisease characterized by excess collagen and other connective tissue components in skin and internalorgans--remains unclear. Given the potential role of matrix enzymes, metalloproteinases, and their tissueinhibitors in pulmonary fibrosis, we assayed the serum concentration of tissue inhibitor of metalloproteinases2 (TIMP-2) in patients with SSc and explored its possible correlation with the duration of Raynaud'sphenomenon, the intensity of sclerosis of the skin, and pulmonary lesions. MATERIAL/METHODS: We studied18 SSc patients, 8 with limited SSc and ten with diffuse. The degree of sclerosis of the skin was measuredusing the Total Skin Scale. Chest x-rays and spirometric examinations were also performed. The presenceand type of antinuclear antibodies (ANA) were determined by indirect immunofluorescence and double immunodiffusionin agar gelatin. Serum TIMP-2 concentration was measured by ELISA. RESULTS: The average serum TIMP-2concentration was not significantly higher in SSc patients than in controls. No statistically significantdifference was found in this respect between limited and diffuse SSc. Despite the lack of correlationbetween the duration of Raynaud's phenomenon, the degree of sclerosis of the skin, and the serum concentrationof TIMP-2, the latter concentration was higher in patients with restrictive pulmonary dysfunction inspirometric testing. CONCLUSIONS: Our research, though involving a small group of patients, points tothe probable role of TIMP-2 in the development of pulmonary fibrosis.

Keywords: Adolescent, Enzyme-Linked Immunosorbent Assay, Raynaud Disease, Research Support, Non-U.S. Gov, Respiratory Function Tests, Scleroderma, Systemic, Skin Diseases, Tissue Inhibitor of Metalloproteinase-2

Add Comment 0 Comments

455 3


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750